Follow the Episurf Medical AB stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are listed on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Episurf Medical AB has recorded 12 insider filings. Market capitalisation: €408.2m. The latest transaction was filed on 9 July 2026 (Sale). Among the most active insiders: Mofast AB (Publ). Every trade is accessible without an account.
12
Insider Decl.
n/a
Thresholds
€7m
5 ops.
Buy Volume
€19,690
1 ops.
Sell Volume
46Σ signal
Buys €7m€19,690 Sells
Fundamental score
Ranked 21,435 of 29,062 companies
35.6
score / 100
Value
21
Quality
50
FCF yld-5.4%
Earn yld-5.1%
EV/EBITDA·
ROE-28%
Gross mgn75%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
2,381,542 shares@ €0.01610.0044% mcap68.9% of flowOptionISINISIN SE0025667470FI:A003R756-1
12 of 12 declarations
About Episurf Medical AB
Episurf Medical AB is a company focused on developing medical solutions for joint injuries. It concentrates on innovative treatments to enhance patients' quality of life.